7-Ethoxyresorufin

CAS No. 5725-91-7

7-Ethoxyresorufin( Resorufin ethyl ether )

Catalog No. M27419 CAS No. 5725-91-7

7-Ethoxyresorufin (7-ER) is a fluorometric substrate for and competitive inhibitor of cytochrome P450, especially CYP1A1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 36 In Stock
5MG 58 In Stock
10MG 96 In Stock
25MG 196 In Stock
50MG 343 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    7-Ethoxyresorufin
  • Note
    Research use only, not for human use.
  • Brief Description
    7-Ethoxyresorufin (7-ER) is a fluorometric substrate for and competitive inhibitor of cytochrome P450, especially CYP1A1.
  • Description
    7-Ethoxyresorufin (7-ER) is a fluorometric substrate for and competitive inhibitor of cytochrome P450, especially CYP1A1.(In Vivo):7-ER inhibited responses to NO and nitrergic nerve stimulation through generation of superoxide radicals. A 7-ER sensitive P450 system may be involved in the bioactivation of GTN and SNP in rat aortic rings, but not in rabbit aorta or rat anococcygeus muscles.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Resorufin ethyl ether
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    5725-91-7
  • Formula Weight
    241.246
  • Molecular Formula
    C14H11NO3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMF : 2 mg/mL (8.29 mM )
  • SMILES
    CCOc1ccc2nc3ccc(=O)cc3oc2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Molnar J, et al. Antimicrobial and immunomodulating effects of some phenolic glycosides. Acta Microbiol Hung. 1989;36(4):425-32.
molnova catalog
related products
  • LY 43578

    LY 43578 is an orally active aromatase inhibitor. LY43578 could inhibit O-demethylation of P-450-dependent p-nitroanisole and N-demethylation of ethylmorphine (IC50 of 0.3 and 5 μm, respectively) in rat liver microsomes.

  • CDD3506

    CDD3506 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.

  • TAK-700 (Orteronel)

    Orteronel(TAK-700) was selected as a candidate for clinical evaluation.